TG/HDL比值与2型糖尿病周围神经病变的相关性
Association of TG/HDL Ratio with Peripheral Neuropathy in Type 2 Diabetes Mellitus
摘要: 糖尿病周围神经病(DPN)是糖尿病患者最常见的慢性并发症。目前2型糖尿病周围神经病发病机制尚未完全清楚，是由多种因素综合作用的结果。其中脂代谢异常在糖尿病进展过程中扮演者重要角色，TG (三酰甘油)是心血管疾病的独立危险因素，HDL具有抗氧化和抗炎症的能力，与单个的血脂指标相比，一些常见血脂比值(TG/高密度脂蛋白(HDL)比值、lg (TG/HDL-C)等)在胰岛素抵抗、糖尿病发病率、代谢综合征、评估β细胞功能、糖尿病大血管及微血管并发症等方面具有临床指导意义。
Abstract: Diabetic peripheral neuropathy (DPN) is the most common chronic complication in diabetic pa-tients. At present, the pathogenesis of peripheral neuropathy in type 2 diabetes is not fully under-stood, and it is the result of a variety of factors. Abnormal lipid metabolism plays an important role in the progression of diabetes. TG (triacylglycerol) is an independent risk factor for cardiovascular diseases, and HDL has antioxidant and anti-inflammatory capabilities. Compared with a single lipid index, some common lipid ratios (TG/high-density lipoprotein (HDL) ratio, lg (TG/HDL-C), etc.) have clinical significance in insulin resistance, diabetes incidence, metabolic syndrome, assessment of β cell function, and diabetes macrovascular and microvascular complications.
文章引用：木拉迪力江·努尔合买提, 米娜瓦尔·胡加艾合买提. TG/HDL比值与2型糖尿病周围神经病变的相关性[J]. 临床医学进展, 2024, 14(1): 1252-1257. https://doi.org/10.12677/ACM.2024.141181

参考文献

[1] Brownlee, M. (2001) Biochemistry and Molecular Cell Biology of Diabetic Complications. Nature, 414, 813-820. [Google Scholar] [CrossRef] [PubMed]
[2] 印小蓉, 胡秀娟, 王淑倩, 等. 血糖变异系数与2型糖尿病周围神经病变的相关性分析[J]. 实用临床医药杂志, 2023, 27(13): 48-52. [Google Scholar] [CrossRef] 
[3] Oprescu, A.I., Bikopoulos, G., Naassan, A., et al. (2007) Free Fatty Acid-Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress in Vitro and in Vivo. Diabetes, 56, 2927-2937. [Google Scholar] [CrossRef] [PubMed]
[4] Huang, S. and Czech, M.P. (2007) The GLUT4 Glucose Transporter. Cell Metabolism, 5, 237-252. [Google Scholar] [CrossRef] [PubMed]
[5] He, A., Liu, X., Liu, L., et al. (2007) How Many Signals Impinge on GLUT4 Activation by Insulin? Cell Signalling, 19, 1-7. [Google Scholar] [CrossRef] [PubMed]
[6] Karlsson, H.K., Chibalin, A.V., Koistinen, H.A., et al. (2009) Kinetics of GLUT4 Trafficking in Rat and Human Skeletal Muscle. Diabetes, 58, 847-854. [Google Scholar] [CrossRef] [PubMed]
[7] Van Schaftingen, E. and Cerin, I. (2002) The Glucose-6-Phosphatase Sys-tem. Biochemical Journal, 362, 513-532. [Google Scholar] [CrossRef] 
[8] Kim, J.K., Wi, J.K. and Woun, J.H. (1996) Plasma Free Fatty Acids De-crease Insulin-Stimulated Skeletal Muscle Glucose Uptake by Suppressing Glycolysis in Conscious Raos. Diabetes, 45, 446-453. [Google Scholar] [CrossRef] 
[9] Sun, Y., Liu, S., Ferguson, S., et al. (2002) Phosphoenolpyruvate Carboxykinase Overexpression Selectively Attenuates Insulin Dsignaling and Hepatic Insulin Sensitivity in Transgenic Mice. Journal of Biological Chemistry, 277, 23301-23307. [Google Scholar] [CrossRef] 
[10] Boden, G., Cheung, P., Stein, T.P., et al. (2002) FFA Cause Hepatic Insulin Resistance by Inhibiting Insulin Suppression of Glycogenolysis. American Journal of Physiology-Endocrinology and Metabolism, 283, 12-19. [Google Scholar] [CrossRef] [PubMed]
[11] Boden, G. and Shulman, G.I. (2002) Free Fatty Acids in Obesity and Type 2 Diabetes: Defining Their Role in the Development of Insulin Resisitance and β Cell Dysfunction. European Journal of Clinical Investigation, 32, 14-23. [Google Scholar] [CrossRef] [PubMed]
[12] Pessin, J.E. and Saltiel, A.R. (2000) Signaling Pathway in Insu-lin Action: Molecular Targets of Insulin Resistance. The Journal of Clinical Investigation, 106, 165-169. [Google Scholar] [CrossRef] 
[13] Saltiel, A.R. and Kahn, C.R. (2001) Insulin Signalling and Regulation of Glucose and Lipid Metabolism. Nature, 414, 799-806. [Google Scholar] [CrossRef] [PubMed]
[14] Haas, M.E., Attie, A.D. and Biddinger, S.B. (2013) The Regulation of ApoB Metabolism by Insulin. Trends in Endocrinology & Metabo-lismb, 24, 391-397. [Google Scholar] [CrossRef] [PubMed]
[15] Kamagate, A., Qu, S., Perdomo, G., et al. (2008) FoxO1 Mediates Insulin-Dependent Regulation of Hepatic VLDL Production in Mice. The Journal of Clinical Investiga-tion, 118, 2347-2364. [Google Scholar] [CrossRef] 
[16] 黄娟, 胡维, 熊丹. 血清LDL与2型糖尿病周围神经病变的相关性研究[J]. 分子诊断与治疗杂志, 2018, 10(5): 352-355, 360. [Google Scholar] [CrossRef] 
[17] Duan, W. and Paka, L. (2005) Distinct Effects of Glu-cose and Glucosamine on Vascular Endothelial and Smooth Muscle Cells: Evidence for a Protective Role for Glucosa-mine in Atherosclerosis. Cardiovascular Diabetology, 4, Article No. 16. [Google Scholar] [CrossRef] [PubMed]
[18] 宋娜, 苏东峰, 高宇, 等. 氧化应激及免疫炎性相关指标与2型糖尿病周围神经病变的相关性分析[J]. 实用预防医学, 2019, 26(5): 626-629. [Google Scholar] [CrossRef] 
[19] Sheetz, M.J. and King, G.L. (2002) Molecular Under-standing of Hyperglycemia’s Adverse Effects for Diabetic Complications. JAMA, 288, 2579-2588. [Google Scholar] [CrossRef] [PubMed]
[20] Vincent, A.M. and Backus, C. (2005) Short-Term Hyperglycemia Produces Oxidative Damage and Apoptosis in Neurons. FASEB Journal, 19, 638-640. [Google Scholar] [CrossRef] [PubMed]
[21] Greene, D.A. and Stevens, M.J. (1999) Glucose-Induced Oxidative Stress and Programmed Cell Death in Diabetic Neuropathy. European Journal of Pharmacology, 375, 217-223. [Google Scholar] [CrossRef] 

为你推荐